Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eptifibatide for microvascular abnormality after PCI in NSTEMI
ChiCTR1900026684Phase 4Recruiting
- Sponsor
- Fuwai Hospital
- Start
- Oct 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4 trial of eptifibatide in Non-ST-segment elevation myocardial infarction (NSTEMI) (2 arms), sponsored by Fuwai Hospital. Primary endpoints: Corrected TIMI Frame Count and Major adverse cardiac events. Started Oct 2019; status: recruiting.
02
Drugs
eptifibatide
03
Conditions
Non-ST-segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on ChiCTR1900026684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026684.